NOVEL Genius of the Rules-Style System Chapter 748 - 409: You’re Such a Genius, How Could You Not Be Sick? _2

Genius of the Rules-Style System

Chapter 748 - 409: You’re Such a Genius, How Could You Not Be Sick? _2
  • Prev Chapter
  • Background
    Font family
    Font size
    Line hieght
    Full frame
    No line breaks
    Text to Speech
  • Next Chapter

Chapter 748: Chapter 409: You’re Such a Genius, How Could You Not Be Sick? _2

"I look forward to the establishment of the Medical Science Center and hope that it will develop into a world-influential center that integrates scientific research, education, and exchange."

After dealing with the media at the press conference, Zhao Yi went to the Biomedical Research Institute, where he discussed the research issues of 2-CV Bing Hydrogen Molecule drugs and Tianqing Molecules with the staff.

Recently, there has been a lot of talk about the 2-CV Bing Hydrogen Molecule, mainly because Wucheng Pharmaceutical Factory has applied for drug approval. The approval process will definitely take a long time, with the fastest estimation being more than half a year. However, as the issue has received widespread attention, news is occasionally reported by the media.

One piece of treatment-related news caught the attention of many people.

Wucheng Pharmaceutical Factory announced the experimental treatment results of the 2-CV Bing Hydrogen Molecule drug. Out of seven volunteers who persisted with the injections, six had their conditions controlled, while one suffered from a severe sudden death.

Meanwhile, the condition of two patients improved, showing a certain increase in the regular immune ability index after using antiviral drugs.

The official medical statement of Wucheng Pharmaceutical Factory on the treatment outcome is, "The 2-CV Bing Hydrogen Molecule effectively inhibits the spread of AIDS in human blood and the central nervous system."

At first glance, the news may not seem significant, but upon further thought, it’s quite extraordinary.

All seven AIDS volunteers who received the 2-CV Bing Hydrogen Molecule treatment were in the late stages of the disease, when various illnesses were erupting. It can be said that they reached an "incurable" stage. It is not surprising that one person died out of the seven. The fact that the immune index of two AIDS patients increased also proves the effectiveness of the 2-CV Bing Hydrogen Molecule.

Although the increased immune index may be due to "antiviral drugs," most antiviral drugs have virtually no effect on patients with advanced AIDS.

The international community also praises the effectiveness of the 2-CV Bing Hydrogen Molecule drug. One major reason is that it is a public achievement without a patent issue, which allows other pharmaceutical manufacturers to produce related drugs.

Next up are the "Tianqing Molecules." ƒгeewёbnovel.com

There is relatively little news about "Tianqing Molecules", and there’s no news about their drug development. The news that does emerge relates to Wucheng Pharmaceutical Factory cooperating with international and domestic medical institutions, providing "Tianqing Molecules" for research purposes.

Three foreign "medical institutions" have successfully obtained "Tianqing Molecules."

The number of domestic cooperative research institutions is relatively larger, with more than a dozen medical research institutions obtaining "Tianqing Molecules." As soon as a cooperation agreement is signed, the representative will get the "Tianqing Molecules" for research.

The reason for this is probably that domestic medical research institutions mostly operate within the same system as Wucheng Pharmaceutical Factory under the supervision of higher authorities, without much problem.

There is no shortage of dissatisfaction in foreign public opinion. For instance, several medical institutions in Europe and the United States hope that Wucheng Pharmaceutical Factory will provide mutated Escherichia coli; otherwise, their research has no meaning. As the mutated Escherichia coli is controlled by Wucheng Pharmaceutical Factory, any drug efficacy they research will ultimately benefit Wucheng Pharmaceutical Factory.

"Although there are no related businesses on the market, confirmed news proves that Tianqing Protein has a good effect against HIV. Combined with the 2CV-Bing Hydrogen Molecule and other anti-AIDS drugs, it may be possible to achieve a cure for AIDS."

"However, everything is in the hands of Wucheng Pharmaceutical Factory!"

"This is a monopoly!"

"The monopoly on the fight against major diseases for all mankind is a naked act of capital exploitation..."

"Drug patents internationally have a time limit, and drug manufacturing materials are the same. Wucheng Pharmaceutical Factory should provide an exact timeline for providing the mutated Escherichia coli."

Of course, that’s impossible, at least not for now!

Although the international voice has some merit, drug patent years generally range from 7 to 10 years; after that, other pharmaceutical manufacturers can replicate the same drug.

This 7 to 10 years time frame allows pharmaceutical manufacturers to recover their R&D costs and make some profit.

However, there are no regulations that require drug manufacturers to share their production materials, nor is there a real way to regulate it.

Before recovering R&D funds and earning the deserved profits, Wucheng Pharmaceutical Factory will definitely not provide the mutated Escherichia coli. However, a timeline can still be developed.

For example, 10 or 20 years after the drug goes on the market.

This timeframe is sufficient for AIDS patients with economic ability to receive treatment, but not enough to bring considerable profits for those without economic ability.

What happens next will depend on the situation.

Everything is changing.

All of this has little to do with Zhao Yi. freewebnøvel.coɱ

Although he receives part of the patent royalties from "Tianqing Protein," he has no decision-making power on the mutated Escherichia coli issue. Thinking about it would be a pure waste of brain cells.

Zhao Yi is more concerned about the progress of laboratory projects. There are several small projects, including Liu Chengjie’s, Yan Yi’s, and Zhang Wei’s, which need genuine attention. Firstly, as a researcher, it is his responsibility to help the members of the laboratory with their projects, and secondly, small projects make the laboratory’s project numbers look slightly better.

Finally, after leaving the Biomedical Research Institute, it was already approaching noon. Zhao Yi went for lunch and returned to his dormitory to receive a surprising invitation.

Use arrow keys (or A / D) to PREV/NEXT chapter